Afuco™ Anti-Human STEAP1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-STEAP1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies against to six-transmembrane epithelial antigen of the prostate-1 (STEAP-1) can inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-564CL |
Pricing | Inquiry |
Host | Human |
Target | STEAP1 |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | ≤6 months at 4°C; ≥6 months at -20°C. |